DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant iPSC hepatocytes (Opti-Heps) with Atelerix’s hydrogel preservation technology, which prevents loss of function and enables even sensitive samples to remain stable at ambient temperatures for up to two weeks.
Stronger Quads May Lower Risk for Knee Replacement Surgery
CHICAGO — Larger quadriceps relative to hamstrings may lower the risk of needing total knee replacement surgery, according to findings from the NIH’s Osteoarthritis Initiative.
November 30, 2023